Impact of body mass index on compliance and persistence to adjuvant breast cancer therapy

Breast

Volumn 21, Issue 4, 2012, Pages 487-492

  Schmid, Seraina Margaretha ^a,b   Eichholzer, Monika ^c   Bovey, Florence ^c   Myrick, Mary Elizabeth ^a   Schötzau, Andreas ^d   Güth, Uwe ^a,b,e  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Breast Center   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d Schötzau and Simmen Institute for Biomathematics   (Switzerland)

^e CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

Author keywords

Adjuvant therapy; Breast cancer; Compliance; Obesity; Overweight; Persistence

Indexed keywords

HORMONE; TRASTUZUMAB;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; COHORT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MOTIVATION; OBESITY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PERSEVERATION; PRIORITY JOURNAL; TREATMENT DURATION;

EID: 84863865186     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2011.11.005     Document Type: Article

References (36)

1. Chlebowski R.T., Aiello E., McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol 2002, 20(4):1128-1143.
2. Litton J.K., Gonzalez-Angulo A.M., Warneke C.L., Buzdar A.U., Kau S.W., Bondy M., et al. Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol 2008, 26(25):4072-4077.
3. Loi S., Milne R.L., Friedlander M.L., McCredie M.R., Giles G.G., Hopper J.L., et al. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2005, 14(7):1686-1691.
4. Carmichael A.R., Bates T. Obesity and breast cancer: a review of the literature. Breast 2004, 13(2):85-92.
5. Reeves G.K., Pirie K., Beral V., Green J., Spencer E., Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007, 335(7630):1134.
6. Majed B., Moreau T., Senouci K., Salmon R.J., Fourquet A., Asselain B. Is obesity an independent prognosis factor in woman breast cancer?. Breast Cancer Res Treat 2008, 111(2):329-342.
7. Carmichael A.R. Obesity as a risk factor for development and poor prognosis of breast cancer. BJOG 2006, 113(10):1160-1166.
8. Porter G.A., Inglis K.M., Wood L.A., Veugelers P.J. Effect of obesity on presentation of breast cancer. Ann Surg Oncol 2006, 13(3):327-332.
9. Stark A., Stahl M.S., Kirchner H.L., Krum S., Prichard J., Evans J. Body mass index at the time of diagnosis and the risk of advanced stages and poorly differentiated cancers of the breast: findings from a case-series study. Int J Obes (Lond) 2010, 34(9):1381-1386.
10. Carmichael A.R. Obesity and prognosis of breast cancer. Obes Rev 2006, 7(4):333-340.
11. Wee C.C., McCarthy E.P., Davis R.B., Phillips R.S. Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care?. Ann Intern Med 2000, 132(9):697-704.
12. Ferrante J.M., Chen P.H., Crabtree B.F., Wartenberg D. Cancer screening in women: body mass index and adherence to physician recommendations. Am J Prev Med 2007, 32(6):525-531.
13. Madarnas Y., Sawka C.A., Franssen E., Bjarnason G.A. Are medical oncologists biased in their treatment of the large woman with breast cancer?. Breast Cancer Res Treat 2001, 66(2):123-133.
14. Griggs J.J., Sorbero M.E., Lyman G.H. Undertreatment of obese women receiving breast cancer chemotherapy. Arch Intern Med 2005, 165(11):1267-1273.
15. Price J.H., Desmond S.M., Krol R.A., Snyder F.F., O'Connell J.K. Family practice physicians' beliefs, attitudes, and practices regarding obesity. Am J Prev Med 1987, 3(6):339-345.
16. Puhl R., Brownell K.D. Bias, discrimination, and obesity. Obes Res 2001, 9(12):788-805.
17. Edge S., Byrd D., Compton C., Fritz A., Greene F., Trotti A., et al. AJCC cancer staging manual 2009, Springer, New York. 7th ed.
18. UICC: TNM classification of malignant tumors 2009, Wiley-Blackwell, Oxford. 7th ed. L. Sobin, M. Gospodarowicz, C. Wittekind (Eds.).
19. Andrade S.E., Kahler K.H., Frech F., Chan K.A. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006, 15(8):565-574. discussion 75-77.
20. Barron T.I., Connolly R., Bennett K., Feely J., Kennedy M.J. Early discontinuation of tamoxifen: a lesson for oncologists. Cancer 2007, 109(5):832-839.
21. Osterberg L., Blaschke T. Adherence to medication. N Engl J Med 2005, 353(5):487-497.
22. Guth U., Huang D.J., Schotzau A., Zanetti-Dallenbach R., Holzgreve W., Bitzer J., et al. Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer. Br J Cancer 2008, 99(3):428-433.
23. Partridge A.H., LaFountain A., Mayer E., Taylor B.S., Winer E., Asnis-Alibozek A. Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 2008, 26(4):556-562.
24. Partridge A.H., Wang P.S., Winer E.P., Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 2003, 21(4):602-606.
25. Goldhirsch A., Wood W.C., Gelber R.D., Coates A.S., Thurlimann B., Senn H.J. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 2007, 18(7):1133-1144.
26. Buist D.S., Ichikawa L., Prout M.N., Yood M.U., Field T.S., Owusu C., et al. Receipt of appropriate primary breast cancer therapy and adjuvant therapy are not associated with obesity in older women with access to health care. J Clin Oncol 2007, 25(23):3428-3436.
27. Deglise C., Bouchardy C., Burri M., Usel M., Neyroud-Caspar I., Vlastos G., et al. Impact of obesity on diagnosis and treatment of breast cancer. Breast Cancer Res Treat 2010, 120(1):185-193.
28. Maskarinec G., Pagano I., Lurie G., Bantum E., Gotay C.C., Issell B.F. Factors affecting survival among women with breast cancer in Hawaii. J Womens Health (Larchmt) 2011, 20(2):231-237.
29. Fontaine K.R., Heo M., Allison D.B. Body weight and cancer screening among women. J Womens Health Gend Based Med 2001, 10(5):463-470.
30. Berz D., Sikov W., Colvin G., Weitzen S. 'Weighing in' on screening mammography. Breast Cancer Res Treat 2009, 114(3):569-574.
31. Destounis S., Newell M., Pinsky R. Breast imaging and intervention in the overweight and obese patient. AJR Am J Roentgenol 2011, 196(2):296-302.
32. Huizinga M.M., Cooper L.A., Bleich S.N., Clark J.M., Beach M.C. Physician respect for patients with obesity. J Gen Intern Med 2009, 24(11):1236-1239.
33. Lash T.L., Fox M.P., Westrup J.L., Fink A.K., Silliman R.A. Adherence to tamoxifen over the five-year course. Breast Cancer Res Treat 2006, 99(2):215-220.
34. Fink A.K., Gurwitz J., Rakowski W., Guadagnoli E., Silliman R.A. Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer. J Clin Oncol 2004, 22(16):3309-3315.
35. Hershman D.L., Kushi L.H., Shao T., Buono D., Kershenbaum A., Tsai W., et al. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol 2010, 28(27):4120-4128.
36. Eichholzer M., Schmid S.M., Bovey F., Jordan P., Rohrmann S., Huang D.J., et al. Impact of overweight and obesity on postmenopausal breast cancer: analysis of 20-year data from Switzerland. Arch Obstet Gynecol 2011 Aug 4, [Epub ahead of print].